Our research interests lie at the interface of chemistry and biology with particular emphasis on nanocarrier mediated intracellular delivery
of payloads for potential applications in various diseases. The field of organelle specific targeted delivery of payloads has been mushrooming.
Our research is directed to develop organelle targeted nanoparticles and to study nanoparticle assisted targeted delivery for possible
applications in cancer, cardiovascular and neurodegenerative diseases. Our lab develops technologies that use a combination of conventional
methods of cancer treatment and immunotherapy in a single nanoparticle platform.
We work in the areas of diagnosis and combination therapies for cancer and cardiovascular disease. Our research program includes design,
synthesis, in vitro, and pre-clinical testing of different nanomedicine platforms. As a research team with a strong background in chemistry,
we aim to provide the scientific community with valuable knowledge that can guide into the discovery of potential drug candidates and vaccines.
Currently we are working in the following research areas:
Project 1: Our research is directed to develop organelle targeted engineered nanoparticles that will offer
several advantages over the existing drugs
Project 2: Our lab develops technologies that use a combination of conventional cancer treatment and
immunotherapy in a single nanoparticle platform to provide powerful tool to treat metastatic cancer.
Project 3: We are working on combination of neuro-protectant stem cell therapy of stroke.
Project 4: We are involved in developing image-guided therapeutic nanoparticles for atherosclerosis.
Immune System Boosted Combination Therapy
Cardiovascular Imaging and Therapy